The oral drug by Merck & Co. smashes all competitors for the treatment and prevention of atherosclerosis.
Jiangsu Hengrui Pharmaceuticals
Posted inInfections, New Drugs, Regulatory
Vivjoa: First Drug for Chronic Vaginal Yeast Infection
Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.